MedTrace Logo

Self-Management for Anxiety, Depression and Somatoform Disorders

NCT01726387 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 364

Last updated 2018-02-06

No results posted yet for this study

Summary

Anxiety, Depression and Somatoform disorders are highly prevalent in primary care. Very often these conditions remain undiscovered and/or untreated.

In order to ease this urgent health care problem in the future, the investigators conduct a cluster-randomized controlled trial, implementing a tandem working cooperation between a nurse practitioner (Counseling Assistant - CA) and a general practitioner (GP) on-site its own practise.

The CA's task is to enhance the patients abilities to engage in a better self-management of their psychological symptoms and complaints, to enhance self-efficacy and empower the patients to tackle problems of daily living.

Conditions

  • Anxiety Depression (Mild or Not Persistent)
  • Major Depressive Disorder, Single Episode, Unspecified
  • Neurotic, Stress-related and Somatoform Disorders

Interventions

BEHAVIORAL

Psychosocial Counseling

Depending on their condition, counseling assistants support patients in self-management support, enhancing self-efficacy, reducing psychological symptoms

BEHAVIORAL

Usual Care

Depending on the conditions, patients get usual care of their general practitioner

Sponsors & Collaborators

  • German Federal Ministry of Education and Research

    collaborator OTHER_GOV

  • Universitätsklinikum Hamburg-Eppendorf

    lead OTHER

Principal Investigators

  • Martin Scherer, Prof. · UK Hamburg-Eppendorf (Germany), Department of Primary Medical Care

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2015-09-30
Completion
2015-09-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01726387 on ClinicalTrials.gov